MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Finance & Investment / Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.
Old Articles: <Older 14671-14680 Newer>
The Motley Fool
May 31, 2006
Stephen D. Simpson
Mirant Tries to Score on a Power Play Its attempt to acquire NRG Energy takes a somewhat nastier turn. Mirant may yet come back with a higher offer. Whatever the case proves to be, it seems likely that independent power players are now going to be getting a lot more attention in the market. mark for My Articles 29 similar articles
The Motley Fool
May 31, 2006
Stephen D. Simpson
Shiny Happy Psychiatric Solutions The growth-through-consolidation story continues apace for Psychiatric Solutions. Investors, caution is warranted here. mark for My Articles 21 similar articles
The Motley Fool
May 31, 2006
Anders Bylund
McData a Big Mac? The designer of switched-fabric storage network switches, fiber-optic storage controllers, and the software that ties them all together has reported first-quarter 2006 pro forma earnings of $0.04 per diluted share, exactly in line with analyst expectations. mark for My Articles 140 similar articles
The Motley Fool
May 31, 2006
Nathan Parmelee
Costco's Consistency Continues: Fool by Numbers The warehouse retailer released third-quarter earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... mark for My Articles 2091 similar articles
The Motley Fool
May 31, 2006
Stephen D. Simpson
Vical Gets a Helping Hand Japan's AnGes MG's Allovectin-7 vaccine is now a risk-free lottery ticket for Vical. If phase 3 trials show adequate efficacy, there's upside. If the trials fail, Vical really doesn't lose much of anything. Investors, take note. mark for My Articles 192 similar articles
The Motley Fool
May 31, 2006
Stephen D. Simpson
More Squealing From the Protein Sector Pork processor Premium Standard isn't immune to the challenges in the meat industry. Still, it's a good company with good prospects trading at what looks like a reasonable valuation. mark for My Articles 101 similar articles
The Motley Fool
May 31, 2006
Brian Gorman
Novartis Gets Its Way FDA approval for Omnitrope suggests Novartis has a bright future in biogenerics, and that's good news for the company's investors. mark for My Articles 118 similar articles
The Motley Fool
May 31, 2006
Stephen D. Simpson
A Sale ... at Tiffany?!?! Investors, when did Tiffany actually start looking like it might -- just maybe -- get cheap? mark for My Articles 143 similar articles
The Motley Fool
May 31, 2006
Alyce Lomax
Google: Green Giant? The search giant's new mashup offers eco-friendly tourism advice. That's nice, but is Google a solid investment at its current stock price? mark for My Articles 1701 similar articles
The Motley Fool
May 31, 2006
Jim Mueller
Too Many Options on the Menu Stock-based compensation weighs down the earnings of restaurants, of all things. Is it really necessary, though, if you are an established, profitable restaurant chain? mark for My Articles 356 similar articles
<Older 14671-14680 Newer>    Return to current articles.